Primary Cutaneous Cryptococcosis Caused by Cryptococcus gatti in an Elderly Patient

According to the spread of Cryptococcus sp., fungal infections can be classified as primary or secondary. In primary cutaneous cryptococcosis, the fungi are restricted to the skin of the patients, without systemic involvement. The incidence of primary cutaneous cryptococcosis is high in patients with immunosuppression, and this type of infection is rarely observed in patients who are immunocompetent. In the present case report, a patient who is immunocompetent and has systemic comorbidity reported that, after skin trauma, ulcerovegetative lesions appeared in the right upper arm; the etiologic agent was identified as Cryptococcus gatti, serotype B. The cutaneous lesions healed completely after 5 months of fluconazole treatment.

[1]  Dayong Wu,et al.  Age-associated alterations in immune function and inflammation , 2022, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2]  J. Sathiyamoorthy,et al.  A holistic review on Cryptococcus neoformans. , 2022, Microbial pathogenesis.

[3]  W. Meyer,et al.  Recent Advances in Cryptococcus and Cryptococcosis , 2021, Microorganisms.

[4]  M. Florek,et al.  Prevalence, Genetic Structure and Antifungal Susceptibility of the Cryptococcus neoformans/C. gattii Species Complex Strains Collected from the Arboreal Niche in Poland , 2021, Pathogens.

[5]  J. Geddes-McAlister,et al.  Proteomics of Cryptococcus neoformans: From the Lab to the Clinic , 2021, International Journal of Molecular Sciences.

[6]  F. Vilar,et al.  Cryptococcosis by Cryptococcus neoformans/Cryptococcus gattii Species Complexes in non-HIV-Infected Patients in Southeastern Brazil , 2021, Revista da Sociedade Brasileira de Medicina Tropical.

[7]  K. Kabashima,et al.  Extensive leg ulcer caused by primary cutaneous cryptococcosis in an immunocompromised patient , 2021, European Journal of Dermatology.

[8]  J. Newberry,et al.  Cryptococcus gattii Meningitis in a Previously Healthy Young Woman: A Case Report , 2021, Clinical practice and cases in emergency medicine.

[9]  J. Baddley,et al.  Cryptococcosis. , 2021, Infectious disease clinics of North America.

[10]  Cameron Harding,et al.  Lung Masses as a Presenting Sign of Disseminated Cryptococcus , 2021, Cureus.

[11]  W. Meyer,et al.  Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Latin America: A Map of Molecular Types, Genotypic Diversity, and Antifungal Susceptibility as Reported by the Latin American Cryptococcal Study Group , 2021, Journal of fungi.

[12]  Kelsey Lawrence,et al.  Disseminated cryptococcosis presenting with cutaneous involvement in an immunocompromised patient. , 2020, Dermatology online journal.

[13]  M. Nanes,et al.  Disseminated Cryptococcosis in An Immunocompetent Host Presenting As Osteomyelitis and Leading to Adrenal Insufficiency. , 2020, The American journal of the medical sciences.

[14]  E. Roilides,et al.  Fulminant cryptococcal meningoencephalitis after successful treatment of primary cutaneous cryptococcosis. , 2020, Germs.

[15]  W. Barańska-Rybak,et al.  Cutaneous cryptococcosis: an underlying immunosuppression? Clinical manifestations, pathogenesis, diagnostic examinations and treatment , 2020, Postepy dermatologii i alergologii.

[16]  L. B. Lopes,et al.  New Approaches for Cryptococcosis Treatment , 2020, Microorganisms.

[17]  J. Baddley,et al.  Cryptococcosis , 2020, Seminars in Respiratory and Critical Care Medicine.

[18]  D. Vugia,et al.  Molecular typing of clinical and environmental isolates of Cryptococcus gattii species complex from southern California, United States , 2019, Mycoses.

[19]  D. Denning,et al.  Pulmonary cryptococcosis: A review of pathobiology and clinical aspects. , 2018, Medical mycology.

[20]  H. Ihn,et al.  [Cutaneous Cryptococcosis]. , 2019, Medical mycology journal.

[21]  D. Engelthaler,et al.  Timing the Origin of Cryptococcus gattii sensu stricto, Southeastern United States , 2018, Emerging infectious diseases.

[22]  E. Castañeda,et al.  The status of cryptococcosis in Latin America , 2018, Memorias do Instituto Oswaldo Cruz.

[23]  F. Wormley,et al.  Innate Immunity against Cryptococcus, from Recognition to Elimination , 2018, Journal of fungi.

[24]  Sukhum Silpa-archa,et al.  Endogenous Cryptococcal Endophthalmitis in Immunocompetent Host: Case Report and Review of Multimodal Imaging Findings and Treatment , 2017, Ocular immunology and inflammation.

[25]  D. Nixon,et al.  Correction: p16INK4a Expression and Immunologic Aging in Chronic HIV Infection , 2017, PloS one.

[26]  Susan Pereira Ribeiro,et al.  p16INK4a Expression and Immunologic Aging in Chronic HIV Infection , 2016, PloS one.

[27]  D. Vasconcelos,et al.  Disseminated cryptococcosis manifested as a single tumor in an immunocompetent patient, similar to the cutaneous primary forms , 2016, Anais brasileiros de dermatologia.

[28]  F. Silveira,et al.  Differential Recruitment of Dendritic Cells Subsets to Lymph Nodes Correlates with a Protective or Permissive T-Cell Response during Leishmania (Viannia) Braziliensis or Leishmania (Leishmania) Amazonensis Infection , 2016, Mediators of inflammation.

[29]  Tianci Chu,et al.  Skeletal cryptococcosis from 1977 to 2013 , 2015, Front. Microbiol..

[30]  T. Sorrell,et al.  Cryptococcus gattii Infections , 2014, Clinical Microbiology Reviews.

[31]  Chieh-Shan Wu,et al.  Primary cutaneous cryptococcosis in an immunocompetent man: A case report , 2013 .

[32]  E. Mylonakis,et al.  Update on the epidemiology and management of cryptococcal meningitis , 2012, Expert opinion on pharmacotherapy.

[33]  M. Fyfe,et al.  Risk Factors for Cryptococcus gattii Infection, British Columbia, Canada , 2011, Emerging infectious diseases.

[34]  J. Perfect,et al.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  L. Hall,et al.  Identification of Cryptococcus gattii by Use of l-Canavanine Glycine Bromothymol Blue Medium and DNA Sequencing , 2009, Journal of Clinical Microbiology.

[36]  K. Wannemuehler,et al.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS , 2009, AIDS.

[37]  W. Meyer,et al.  Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. , 2008, Memorias do Instituto Oswaldo Cruz.

[38]  J. Jarvis,et al.  HIV-associated cryptococcal meningitis. , 2007, AIDS.

[39]  Kun‐Lun Huang,et al.  Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. , 2006, Chest.

[40]  X. Ai‐e,et al.  Two cases of cutaneous cryptococcosis , 2005, Mycoses.

[41]  J. Christianson,et al.  Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. , 2003, Medical mycology.

[42]  E. Heins-Vaccari,et al.  Primary cutaneous cryptococcosis due to Cryptococcus neoformans var. gattii serotype B, in an immunocompetent patient. , 2002, Revista do Instituto de Medicina Tropical de Sao Paulo.

[43]  R. M. Warren,et al.  Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  J. Baran,et al.  Primary cutaneous cryptococcosis of the nose in an immunocompetent woman. , 2000, Journal of the American Academy of Dermatology.

[45]  M. Saag,et al.  Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis , 2000 .

[46]  M. Saag,et al.  Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  L. Meuleman,et al.  Cutaneous cryptococcosis in corticosteroid-treated patients without AIDS. , 1996, Acta clinica Belgica.

[48]  J. O. Hill.  CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract , 1992, The Journal of experimental medicine.

[49]  S. Waltman,et al.  Cryptococcal endophthalmitis after corneal transplantation. , 1978, The New England journal of medicine.

[50]  J. Chleboun,et al.  Skeletal cryptococcosis. , 1977, The Journal of bone and joint surgery. American volume.